Latest news
09-11-2021 - MRC Funding to Improve the Delivery of Nucleic Acid Therapeutics
Funding will enable a consortium to tackle major barriers to improve the delivery of nucleic acid therapeutics (NAT).
UK Research and Innovation (UKRI), the Medical Research Council (MRC), Engineering and Physical Sciences Research Council (EPSRC), Biotechnology and Biological Sciences Research Council (BBSRC) and Innovate UK have together launched a call as part of the £30 million Nucleic Acid Therapy Accelerator (NATA) programme, which is funded by the Strategic Priorities Fund to support multidisciplinary approaches to the development of nucleic acid therapeutics (NAT).
[...]